Difference between revisions of "DZI20-199-Case-6"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 61: Line 61:
 
|subject=Z0FBQUFBQmYxUUZMb0FfeWJNN3ZqcFR0MEVlSzhQS1NXaThIdm1JMHktT3c0cjVwaXoxV3YwbHFsbkZzclgxZjJBRDdxOGVQMWFGNTJ2aU1iNGhVMjk0NlMyZ2hSekwwVXc9PQ
 
|subject=Z0FBQUFBQmYxUUZMb0FfeWJNN3ZqcFR0MEVlSzhQS1NXaThIdm1JMHktT3c0cjVwaXoxV3YwbHFsbkZzclgxZjJBRDdxOGVQMWFGNTJ2aU1iNGhVMjk0NlMyZ2hSekwwVXc9PQ
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Mjf79
 +
|authoredOn=December 12, 2020 05:40:26 PM
 
}}
 
}}

Latest revision as of 13:59, December 9, 2024

DZI20-199-Case-6
pancreas mass - whipple

FX2: common bile duct margin FX3: pancreatic transection margin

FX4: Mass to uncinate
FX2 (common bile duct margin): TINEM

FX3 (pancreatic transection margin): TINEM (permanent: chronic pancreatitis)

FX4 (Mass to uncinate): adenocarcinoma, viable cells are present. Uncinate margin, negative for tumor (permanent: ductal adenocarcinoma)
December 31, 1969 7:00:00 PM